JAK2 and myelodysplastic syndrome: Based on the morphology, immunology, cytogenetics, and molecular biology of bone marrow cells, the patient was diagnosed with myelodysplastic syndrome (MDS, +8, -7, IPSS-R 5.5 points, JAK2, ROBO2, and CROCC mutations).